Abstract

Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Modern management of differentiated thyroid cancer.
Jason B Cohen ... I Ross Mcdougall
Cancer Biotherapy & Radiopharmaceuticals | VOL. 18
Jason B Cohen, et. al.Jason B Cohen ... I Ross Mcdougall
01 Oct 2003
131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
Hung Q Dam ... Sung M Kim
Radiology | VOL. 232
Hung Q Dam, et. al.Hung Q Dam ... Sung M Kim
01 Aug 2004
Thyroid Stunning: Fact or Fiction?
I Ross Mcdougall ... Andrei Iagaru
Seminars in Nuclear Medicine Lung Scan Update (Part I) | VOL. 41
I Ross Mcdougall, et. al.I Ross Mcdougall ... Andrei Iagaru
25 Jan 2011
The Molecular Effect of Diagnostic Absorbed Doses from 131I on Papillary Thyroid Cancer Cells In Vitro.
Mariusz Stasiołek ... Anna Merecz-Sadowska
Molecules (Basel, Switzerland) | VOL. 22
Mariusz Stasiołek, et. al.Mariusz Stasiołek ... Anna Merecz-Sadowska
15 Jun 2017
View more papers

More From: Nuclear medicine communications

Paper Title
Journal
Date
Author
Enhancing precision in bone metastasis diagnosis for lobular breast cancer: reassessing the role of 18F-FDG PET/CT.
Sharjeel Usmani ... Rashid Al Sukati
Nuclear medicine communications | VOL. -
Sharjeel Usmani, et. al.Sharjeel Usmani ... Rashid Al Sukati
22 Jul 2024
Radionuclide therapy of bevacizumab-based PNA-mediated pretargeting.
Jingxuan Yan ... Yue Chen
Nuclear medicine communications | VOL. -
Jingxuan Yan, et. al.Jingxuan Yan ... Yue Chen
16 Jul 2024
Quantitative bone single photon emission computed tomography/computed tomography in symptomatic and asymptomatic foot and ankle osteoarthritis.
Martin Ulrich ... Ujwal Bhure
Nuclear medicine communications | VOL. -
Martin Ulrich, et. al.Martin Ulrich ... Ujwal Bhure
10 Jul 2024
Internal dosimetry and biodistribution of indigenously prepared 177Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximab.
Yeshwanth Edamadaka ... Sandip Basu
Nuclear medicine communications | VOL. -
Yeshwanth Edamadaka, et. al.Yeshwanth Edamadaka ... Sandip Basu
28 Jun 2024
View more papers